Leading clinician researchers Professor Mark Middleton and Dr Anna Schuh discuss advances in personalised medicine
Personalised medicine utilises advances in DNA sequencing technology to classify a tumours according to genetic make-up instead of where they are in the body – allowing cancer treatment to be tailored to the individual patient.
People may have the ‘same’ cancer, such as lung or breast cancer, but can have different genetic forms of the disease so responses to treatment can vary. Likewise, cancers growing in different parts of the body may share the same genetic blueprint and so respond to similar treatments.
In this public lecture, leading clinician researchers Professor Mark Middleton and Dr Anna Schuh discuss advances in personalised medicine being pioneered at Oxford University Hospitals.